Transaction by Person Discharging Managerial Responsibilities
Further details are set out in the attached notification, made in accordance with the requirements of the EU Market Abuse Regulation (since it forms part of
|
1
|
Details of the person discharging managerial responsibilities / person closely associated
|
|||||
|
a)
|
|
|
||||
|
2
|
Reason for the notification
|
|||||
|
a)
|
Position/status
|
Non-Executive Director |
||||
|
b)
|
Initial notification /Amendment
|
Initial notification |
||||
|
3
|
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
|
|||||
|
a)
|
|
|
||||
|
b)
|
LEI
|
PY6ZZQWO2IZFZC3IOL08 |
||||
|
4
|
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
|
|||||
|
a)
|
Description of the financial instrument, type of instrument
Identification code
|
AstraZeneca PLC American Depositary Shares
CUSIP: 0463531089
|
||||
|
b)
|
Nature of the transaction
|
Acquisition of AstraZeneca PLC American Depositary Shares through the reinvestment of the first interim dividend of the Company, in respect of the year ending |
||||
|
c)
|
Price(s) and volume(s)
|
|
||||
|
d)
|
Aggregated information
- Aggregated volume
- Price
|
Not applicable - single transaction
|
||||
|
e)
|
Date of the transaction
|
|
||||
|
f)
|
Place of the transaction
|
XNAS |
||||
Contacts
For details on how to contact the Investor Relations Team, please click here. For Media contacts, click here.
Company Secretary
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the